National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
70.36
+1.04 (1.50%)
Jan 21, 2025, 4:00 PM EST - Market closed
National Health Investors Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for NHI stock have an average target of 73, with a low estimate of 63 and a high estimate of 92. The average target predicts an increase of 3.75% from the current stock price of 70.36.
Analyst Consensus: Buy
* Price targets were last updated on Dec 23, 2024.
Analyst Ratings
The average analyst rating for NHI stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 5 | 4 | 4 | 4 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $78 → $72 | Hold | Maintains | $78 → $72 | +2.33% | Dec 23, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Initiates $81 → $86 | Buy → Hold | Initiates | $81 → $86 | +22.23% | Oct 1, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $92 | Strong Buy | Initiates | $92 | +30.76% | Sep 24, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $65 → $78 | Hold | Maintains | $65 → $78 | +10.86% | Aug 30, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $58 → $65 | Hold | Maintains | $58 → $65 | -7.62% | Jun 26, 2024 |
Financial Forecast
Revenue This Year
325.15M
Revenue Next Year
371.06M
from 325.15M
Increased by 14.12%
EPS This Year
2.98
from 3.13
Decreased by -4.60%
EPS Next Year
3.16
from 2.98
Increased by 5.96%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 355.4M | 460.3M | 561.4M | |||
| Avg | 325.2M | 371.1M | 430.8M | |||
| Low | 300.4M | 329.5M | 349.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 41.6% | 51.3% | |||
| Avg | - | 14.1% | 16.1% | |||
| Low | - | 1.3% | -5.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.16 | 3.37 | 3.48 |
| Avg | 2.98 | 3.16 | 3.32 |
| Low | 2.82 | 3.01 | 3.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.1% | 13.0% | 10.0% |
| Avg | -4.6% | 6.0% | 5.2% |
| Low | -9.7% | 0.9% | 1.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.